PMID: 12556293

Bhandari A, Crawford SE, Huang L, Reenstra WW
Effects of oral genistein in mice.
Pediatr Pathol Mol Med. 2003 Mar-Apr;22(2):131-41., [PubMed]
Sentences
No. Mutations Sentence Comment
18 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12556293:18:145
status: NEW
view ABCC7 p.Gly551Asp details
Genistein also has been shown to potentiate PKA-dependent activation of the most common CFTR mutant DF508 and another common CF causing mutation G551D [3,6]. Login to comment
105 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12556293:105:43
status: NEW
view ABCC7 p.Gly551Asp details
A similar e¡ect hasbeen observed with G551D, another common CFmutationthat is more e/ciently targetedtothe plasma membrane [6]. Login to comment
106 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12556293:106:89
status: NEW
view ABCC7 p.Gly551Asp details
If similar e¡ects can be achieved in vivo, and with the proviso that DF508-CFTR and G551D-CFTR are present in the apical membrane, genistein could be of considerable therapeutic bene't to CF patients with these mutations. Login to comment
120 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12556293:120:291
status: NEW
view ABCC7 p.Gly551Asp details
However, since its utility as a treatment for CF would require continuous treatment, we chose to study the e¡ects of relatively long-term ad libitum consumption of genistein before assessing the ability of genistein to improve the morbidity and mortality of knockin mice with DF508- or G551D-CFTR. Login to comment